Stavrakas, P.; Christou, E.E.; Nasikas, V.; Koutsiouki, C.; Vakalis, A.; Asteriadis, S.; Panos, G.D.; Tranos, P.
Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. Medicina 2025, 61, 488.
https://doi.org/10.3390/medicina61030488
AMA Style
Stavrakas P, Christou EE, Nasikas V, Koutsiouki C, Vakalis A, Asteriadis S, Panos GD, Tranos P.
Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. Medicina. 2025; 61(3):488.
https://doi.org/10.3390/medicina61030488
Chicago/Turabian Style
Stavrakas, Panagiotis, Evita Evangelia Christou, Vasileios Nasikas, Chrysoula Koutsiouki, Athanasios Vakalis, Solon Asteriadis, Georgios D. Panos, and Paris Tranos.
2025. "Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema" Medicina 61, no. 3: 488.
https://doi.org/10.3390/medicina61030488
APA Style
Stavrakas, P., Christou, E. E., Nasikas, V., Koutsiouki, C., Vakalis, A., Asteriadis, S., Panos, G. D., & Tranos, P.
(2025). Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. Medicina, 61(3), 488.
https://doi.org/10.3390/medicina61030488
